WHO ICTRP trial

Phase II study of Docetaxel, Cisplatin and S1 followed by surgery in advanced…

JPRN-UMIN000006036 · Japan Primary Registries Network (JPRN) · Recruiting

Key facts

Trial ID JPRN-UMIN000006036
Public title Phase II study of Docetaxel, Cisplatin and S1 followed by surgery in advanced gastric cancer with lymph node metastasis of the paraaorta
Scientific title Phase II study of Docetaxel, Cisplatin and S1 followed by surgery in advanced gastric cancer with lymph node metastasis of the paraaorta - Paraaorta GC preoperative DCS Phase II
Primary sponsor Digestive Disease Support Organization (DDSO)
Secondary sponsors 1)Department of surgery, Toyama prefectural central hospital 2)1st Department of Surgery Faculty of Medicine University of Fukui 3)Department of surgery, Saiseikai Yahata general hospital
Registry Japan Primary Registries Network (JPRN)
Recruitment status Recruiting
Study type Interventional
Phase Phase II
Countries Japan
Conditions gastric cancer with para-aortic lymph node metastasis
Interventions Preoperative chemotherapy with Docetalxel+CDDP+S-1 followed by gastrectomy with D2 and para-aortic nodal dissection
Registration date Jan 8, 2011
Target size 30
Registry page center6.umin.ac.jp

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations